+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In Vitro Diagnostics Market Outlook, 2021

  • Report
  • 84 Pages
  • September 2021
  • Region: Global
  • Frost & Sullivan
  • ID: 5456997

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth.


The competitive nature of the In Vitro Diagnostics (IVD) industry has unfolded through the COVID-19 pandemic, as it continued to serve the healthcare domain and successfully reach a revenue of $85.91 billion in 2020. Clinical chemistry and immunoassays dominate the revenue share; molecular diagnostics and point-of-care-testing continue to grow at the highest rates; and tissue diagnostics and hemostasis will experience moderate growth followed by rest of the technology segments.


The top-10 companies serving the IVD industry together accounted for 65.2% of the global revenue in 2020, while the top-20 companies together made up 78.8% of the global proceeds. The NA region, primarily with contributions from the US, leads the market, maintaining its stronghold on the IVD industry. APAC, primarily driven by Japan, China, and India, along with the other growing economies will experience the highest growth rate, while Europe will continue to grow at a slower pace. Overall, this research service offers insightful analysis in the form of overall forecast, region, and technology segment wise analysis, benchmarking of top participants, and key growth opportunities that will shape the industry.


Table of Contents

1. Strategic Imperatives
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the In Vitro Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™


2. Growth Opportunity Analysis - In Vitro Diagnostics Industry
In Vitro Diagnostics Market Scope of Analysis
In Vitro Diagnostics Market Based on Workflow
In Vitro Diagnostics Market Segmentation Based on Technologies
In Vitro Diagnostics Market Definition Technology Segments
In Vitro Diagnostics Market Segmentation Based on Region
Key Competitors for In Vitro Diagnostics Market
Key Growth Metrics for In Vitro Diagnostics Market
In Vitro Diagnostics Market Growth Outlook Summary
Decentralized Testing to Drive Growth - In Vitro Diagnostics Market
Growth Drivers for In Vitro Diagnostics Market
Growth Restraints for In Vitro Diagnostics Market
Forecast Assumptions - In Vitro Diagnostics Market
Revenue Forecast - In Vitro Diagnostics Market
Revenue Forecast by Workflow - In Vitro Diagnostics Market
Revenue Forecast by Technology - In Vitro Diagnostics Market
Revenue Forecast by Region - In Vitro Diagnostics Market
Revenue Forecast Analysis - In Vitro Diagnostics Market
Revenue Forecast Analysis by Workflow Segments - In Vitro Diagnostics Market
Revenue Forecast Analysis by Selective Technology Segments - In Vitro Diagnostics Market
Revenue Forecast Analysis by Region - In Vitro Diagnostics Market
Competitive Environment - In Vitro Diagnostics Market
Revenue Share - In Vitro Diagnostics Market
Revenue Share Analysis - In Vitro Diagnostics Market
Competitor Matrix - In Vitro Diagnostics Market
Competitor Segment Ranking - In Vitro Diagnostics Market
Recent Notable Activities - In Vitro Diagnostics Market


3. Growth Opportunity Analysis - Clinical Chemistry and Immunoassay
Key Growth Metrics for Clinical Chemistry and Immunoassay
Revenue Forecast - Clinical Chemistry and Immunoassay
Forecast Analysis - Clinical Chemistry and Immunoassay


4. Growth Opportunity Analysis - Molecular Diagnostics
Key Growth Metrics for Molecular Diagnostics
Revenue Forecast - Molecular Diagnostics
Forecast Analysis - Molecular Diagnostics


4. Growth Opportunity Analysis - Tissue Diagnostics
Key Growth Metrics for Tissue Diagnostics
Revenue Forecast - Tissue Diagnostics
Forecast Analysis - Tissue Diagnostics


5. Growth Opportunity Analysis - Point-of-Care-Testing
Key Growth Metrics for Point-of-Care-Testing
Revenue Forecast - Point-of-Care-Testing
Forecast Analysis - Point-of-Care-Testing


6. Growth Opportunity Analysis - In Vitro Diagnostics Market: North America
Key Growth Metrics for In Vitro Diagnostics Market - North America
Revenue Forecast for In Vitro Diagnostics Market - North America
Forecast Analysis by Technology for In Vitro Diagnostics Market - North America


7. Growth Opportunity Analysis - In Vitro Diagnostics Market: Europe
Key Growth Metrics for In Vitro Diagnostics Market - Europe
Revenue Forecast for In Vitro Diagnostics Market - Europe
Forecast Analysis by Technology for In Vitro Diagnostics Market - Europe


8. Growth Opportunity Analysis - In Vitro Diagnostics Market: Asia-Pacific (APAC)
Key Growth Metrics for In Vitro Diagnostics Market - APAC
Revenue Forecast for In Vitro Diagnostics Market - APAC
Forecast Analysis by Technology for In Vitro Diagnostics Market - APAC


9. Growth Opportunity Universe - In Vitro Diagnostics
Growth Opportunity 1: POCT Instruments for Diagnosis of Respiratory Infections
Growth Opportunity 2: Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics
Growth Opportunity 3: Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology
Growth Opportunity 4: Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time


10. Next Steps
Your Next Steps
List of Exhibits
Legal Disclaimer